Reflex BRAF Testing in Thyroid Fine-Needle Aspiration Biopsy with Equivocal and Positive Interpretation: A Prospective Study

被引:49
作者
Adeniran, Adebowale J. [1 ]
Theoharis, Constantine [1 ]
Hui, Pei [1 ]
Prasad, Manju L. [1 ]
Hammers, Lynwood [2 ]
Carling, Tobias [3 ]
Udelsman, Robert [3 ]
Chhieng, David C. [1 ]
机构
[1] Yale Univ, Dept Pathol, New Haven, CT 06520 USA
[2] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06520 USA
[3] Yale Univ, Dept Surg, New Haven, CT 06520 USA
关键词
BRAF(V600E) MUTATION; PREOPERATIVE EVALUATION; PAPILLARY CARCINOMAS; V600E MUTATION; DIAGNOSIS; CANCER; NODULES; CLASSIFICATION; PREVALENCE; MANAGEMENT;
D O I
10.1089/thy.2011.0021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The BRAF V600E mutation has been reported in 50%-80% of papillary thyroid carcinoma (PTC) cases and is highly specific for PTC. Reflex BRAF testing may improve the diagnostic accuracy of thyroid fine-needle aspiration (FNA) tests having equivocal cytologic interpretations and provide prognostic information that helps guide management in patients with PTC. Patients and Methods: Cases with equivocal thyroid FNA readings (indeterminate and suspicious for PTC) or a positive diagnosis for PTC and concomitant BRAF mutation analysis were included in this prospective study. BRAF mutation analysis was performed by polymerase chain reaction combined with single-strand conformation polymorphism gel electrophoresis using lavage fluid obtained from needle rinsing. The results of histopathologic follow-up were correlated with the cytologic interpretations and BRAF status. Results: One hundred fifty-seven FNAs with equivocal or positive cytologic interpretations were eligible for the study. All but one (99.4%) FNAs were found to have sufficient DNA quality and quantity for the assay. Based on the follow-up diagnosis of nodules after surgical resection, the sensitivity for diagnosing PTC was 63.3% with cytology alone and 80.0% with the combination of cytology and BRAF testing, respectively. No false positives were noted with either cytology or BRAF mutation analysis. All PTCs with extrathyroidal extension and of tall-cell variant were postive for BRAF mutation. Conclusions: BRAF V600E mutation analysis can be easily performed on cytologic preparation using lavage fluids obtained from needle rinsing. By combining morphologic evaluation and BRAF testing, there is a substantial improvement in the preoperative identification of PTC when compared with cytology alone. Patients with equivocal cytologic diagnosis and BRAF V600E mutation are candidates for total thyroidectomy +/- central lymph node dissection.
引用
收藏
页码:717 / 723
页数:7
相关论文
共 43 条
  • [1] Amrikachi M, 2001, ARCH PATHOL LAB MED, V125, P484
  • [2] [Anonymous], MOD PATHOL
  • [3] Preoperative evaluation and predictive value of fine-needle aspiration and frozen section of thyroid nodules
    Boyd, LA
    Earnhardt, RC
    Dunn, JT
    Frierson, HF
    Hanks, JB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (05) : 494 - 502
  • [4] The National Cancer Institute Thyroid fine-needle aspiration state-of-the-science conference - Inspingtion for a uniform terminology linked to management guidelines
    Cibas, Edmund S.
    Sanchez, Miguel A.
    [J]. CANCER CYTOPATHOLOGY, 2008, 114 (02): : 71 - 73
  • [5] BRAF mutation in papillary thyroid carcinoma
    Cohen, J
    Xing, MZ
    Mambo, E
    Guo, ZM
    Wu, GG
    Trink, B
    Beller, U
    Westra, WH
    Ladenson, PW
    Sidransky, D
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08) : 625 - 627
  • [6] Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid:: A potential application for the preoperative assessment of thyroid nodules
    Cohen, Y
    Rosenbaum, E
    Clark, DP
    Zeiger, MA
    Umbricht, CB
    Tufano, RP
    Sidransky, D
    Westra, WH
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (08) : 2761 - 2765
  • [7] Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
    Cooper, David S.
    Doherty, Gerard M.
    Haugen, Bryan R.
    Kloos, Richard T.
    Lee, Stephanie L.
    Mandel, Susan J.
    Mazzaferri, Ernest L.
    McIver, Bryan
    Pacini, Furio
    Schlumberger, Martin
    Sherman, Steven I.
    Steward, David L.
    Tuttle, R. Michael
    [J]. THYROID, 2009, 19 (11) : 1167 - 1214
  • [8] BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma
    Costa, Angela M.
    Herrero, Agustin
    Fresno, Manuel F.
    Heymann, Jonas
    Antonio Alvarez, Jose
    Cameselle-Teijeiro, Jose
    Garcia-Rostan, Ginesa
    [J]. CLINICAL ENDOCRINOLOGY, 2008, 68 (04) : 618 - 634
  • [9] Mutations of the BRAF gene in human cancer
    Davies, H
    Bignell, GR
    Cox, C
    Stephens, P
    Edkins, S
    Clegg, S
    Teague, J
    Woffendin, H
    Garnett, MJ
    Bottomley, W
    Davis, N
    Dicks, N
    Ewing, R
    Floyd, Y
    Gray, K
    Hall, S
    Hawes, R
    Hughes, J
    Kosmidou, V
    Menzies, A
    Mould, C
    Parker, A
    Stevens, C
    Watt, S
    Hooper, S
    Wilson, R
    Jayatilake, H
    Gusterson, BA
    Cooper, C
    Shipley, J
    Hargrave, D
    Pritchard-Jones, K
    Maitland, N
    Chenevix-Trench, G
    Riggins, GJ
    Bigner, DD
    Palmieri, G
    Cossu, A
    Flanagan, A
    Nicholson, A
    Ho, JWC
    Leung, SY
    Yuen, ST
    Weber, BL
    Siegler, HF
    Darrow, TL
    Paterson, H
    Marais, R
    Marshall, CJ
    Wooster, R
    [J]. NATURE, 2002, 417 (6892) : 949 - 954
  • [10] Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma
    Domingues, R
    Mendonça, E
    Sobrinho, L
    Bugalho, MJ
    [J]. CYTOPATHOLOGY, 2005, 16 (01) : 27 - 31